HemaSphere
(Jun 2022)
P1326: FACTORS ASSOCIATED WITH THE OUTCOME OF ALLO-HSCT FOR ADVERSE-CYTOGENETIC RISK ACUTE MYELOID LEUKEMIA
- J. M. Cerezo-Martin,
- A. Avendaño,
- S. Fernandez-Luis,
- J. A. Calvo,
- E. Ocio,
- M. Colorado,
- A. Bermudez
Affiliations
- J. M. Cerezo-Martin
- 1 Hematology, Marques de Valdecilla University Hospital, santander
- A. Avendaño
- 2 Hematology, Salamanca University Hospital, Salamanca, Spain
- S. Fernandez-Luis
- 1 Hematology, Marques de Valdecilla University Hospital, santander
- J. A. Calvo
- 1 Hematology, Marques de Valdecilla University Hospital, santander
- E. Ocio
- 1 Hematology, Marques de Valdecilla University Hospital, santander
- M. Colorado
- 1 Hematology, Marques de Valdecilla University Hospital, santander
- A. Bermudez
- 1 Hematology, Marques de Valdecilla University Hospital, santander
- DOI
-
https://doi.org/10.1097/01.HS9.0000848168.22862.f7
- Journal volume & issue
-
Vol. 6
pp.
1211
– 1212
WeChat QR code